March 2018
TAE Life Sciences Inks $40M Series A Funding
TAE Life Sciences Raises $40M For Neutron Beam Cancer Treatment
TAE Raises $40M To Develop New Targeted Radiotherapy
$40 Million for Boron Neutron Capture Therapy
A Surprise Application To Cancer
TAE Life Sciences Is Trying To Make Boron Neutron Capture Therapy More Accessible
TAE Life Sciences Announces $40 Million In Venture Capital
TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding
Have questions about BNCT? Get answers on our new BNCT Forum